World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
149
Citations
78086
World Ranking
1209
National Ranking
699

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Stephen J. Forman is affiliated with the City Of Hope National Medical Center in the United States. Their research output focuses primarily on medicine, with a significant concentration in oncology and hematology. Other subfields of study include public health, environmental and occupational health, immunology, and genetics.

The scientist's main topics of work are centered on:

  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Immune Cell Function and Interaction

Among the recent papers associated with this researcher are:

  • Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors, 2020, Science Translational Medicine
  • Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial, 2024, Nature Medicine
  • Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma, 2020, Science Translational Medicine
  • Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL, 2020, Blood
  • CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies, 2020, Cancer Discovery

Frequent co-authors collaborating with this scientist include:

  • Ryotaro Nakamura
  • Guido Marcucci
  • Monzr M. Al Malki
  • Ibrahim Aldoss
  • Anthony S. Stein

Common venues for their publications are:

  • Blood
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Blood Advances
  • Cancer Research

Stephen J. Forman is recognized as a Member of the Association of American Physicians. Their scholarly output spans over 850 publications in medicine and its subfields, contributing to advancements in cell-based therapies and hematologic malignancies.

Best Publications

  • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

    Marilyn L. Slovak;Kenneth J. Kopecky;Peter A. Cassileth;David H. Harrington

  • Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

    Brown Ce;Alizadeh D;Starr R;Weng L

  • Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

    Max S. Topp;Nicola Gökbuget;Anthony S. Stein;Gerhard Zugmaier

  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

    William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift

  • Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.

    Brian G. Till;Brian G. Till;Michael C. Jensen;Jinjuan Wang;Eric Y. Chen

  • A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

    Gerhard M. Schmidt;David A. Horak;Joyce C. Niland;Steven R. Duncan

  • A transgene encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

    Xiuli Wang;Wen Chung Chang;ChingLam W. Wong;David Colcher

  • CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.

    Brian G. Till;Brian G. Till;Michael C. Jensen;Michael C. Jensen;Jinjuan Wang;Xiaojun Qian

  • Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.

    Ravi Bhatia;Melissa Holtz;Ning Niu;Rachel Gray

  • Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate.

    E.L. Sievers;F.R. Appelbaum;R.T. Spielberger;S.J. Forman

  • Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

    Christine E. Brown;Behnam Badie;Michael E. Barish;Lihong Weng

  • CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells

    Claudia M. Kowolik;Max S. Topp;Sergio Gonzalez;Timothy Pfeiffer

  • Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans

    Michael C. Jensen;Leslie Popplewell;Laurence J. Cooper;David DiGiusto

  • Thomas' hematopoietic cell transplantation

    Frederick R. Appelbaum;Stephen J. Forman;Robert S. Negrin;Karl G. Blume

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor study

    Smita Bhatia;Liton Francisco;Andrea Carter;Can Lan Sun

  • Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

    Elizabeth McLaughlin‐Taylor;Hema Pande;Stephen J. Forman;Becky Tanamachi

  • Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

    Mary E. D. Flowers;Pablo M. Parker;Laura J. Johnston;Alice V. B. Matos

  • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

    David G. Maloney;Arthur J. Molina;Firoozeh Sahebi;Keith E. Stockerl-Goldstein

  • RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

    David L. DiGiusto;Amrita Krishnan;Lijing Li;Haitang Li

Frequent Co-Authors

Smita Bhatia
Smita Bhatia University of Alabama at Birmingham
Ravi Bhatia
Ravi Bhatia University of Alabama at Birmingham
Christine E. Brown
Christine E. Brown City Of Hope National Medical Center
John A. Zaia
John A. Zaia City Of Hope National Medical Center
George Somlo
George Somlo City Of Hope National Medical Center
Karl G. Blume
Karl G. Blume Stanford University
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Arturo Molina
Arturo Molina Sutro Biopharma
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Michael C. Jensen
Michael C. Jensen Seattle Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers but seeking flexibility, online degrees offer a variety of accessible entry and advancement options. Nursing programs delivered online, for example, provide pathways for both newcomers and experienced professionals.

If you are a registered nurse looking to advance your education, online rn to bsn programs without clinical requirements offer a convenient route to a higher degree by removing traditional barriers like mandatory onsite practicals. For those wanting to move further into leadership or specialized practice, earning a doctorate can be streamlined with the shortest post master's dnp program, designed to accelerate your progress.

If you’re concerned about balancing work or family with doctoral study, consider an easiest dnp program online that caters to working nurses and emphasizes flexibility. For those just beginning their nursing journey, online lpn programs provide an efficient way to start a career in healthcare with minimal disruption to your lifestyle.

These online healthcare degrees create new career pathways, break down traditional barriers, and help you pursue your professional goals at your own pace.

Best Scientists Citing Stephen J. Forman

Trending Scientists